CF
IMCR icon

Cantor Fitzgerald’s Immunocore IMCR Stock Holding History

Cantor Fitzgerald’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Hold
50,500
– – 0.02% 165
2025
Q4 		$1.75M Sell
50,500
-24,500
-33% -$865K 0.03% 141
2025
Q3 		$2.72M Hold
75,000
– – 0.03% 139
2025
Q2 		$2.35M Buy
+75,000
New +$2.33M 0.04% 99

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Cantor Fitzgerald's IMCR Position: Q1 2026 in Review

Cantor Fitzgerald opened a new position in Immunocore (IMCR) in Q1 2026: 250,211 shares worth $7.54M. The stake represents 0.11% of the portfolio and ranks #88 among its holdings. This is a return to the name: Cantor Fitzgerald previously reported a position in IMCR as recently as Q2 2025.

Cantor Fitzgerald first reported a position in IMCR in Q2 2024 and has held it in 5 quarters since. The position peaked at $8.61M in Q2 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Cantor Fitzgerald held 250,211 shares of Immunocore worth $7.54M as of Q1 2026.
  • Immunocore was a new Cantor Fitzgerald position in Q1 2026.
  • Immunocore made up 0.11% of Cantor Fitzgerald's portfolio in Q1 2026, its #88 holding.
  • Cantor Fitzgerald first reported a position in Immunocore in Q2 2024 and has held it in 5 quarters since.
  • Cantor Fitzgerald's Immunocore position peaked at $8.61M in Q2 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Cantor Fitzgerald's 13F filing for Q1 2026, filed 15 May 2026.